UK’s GSK announces $30 billion U.S. pharma investment amid Trump state visit
Rafael Henrique | LightoKet | Getty Images
Britain GSK On Wednesday, President Donald Trump was the last pharmaceutical company to invest a buffer in the United States, as he was in the UK for a three -day state visit.
The drug producer has decided to develop US research and development (R) and invest at least $ 30 billion to produce for the next five years.
Investment, drug producer, “new generation of biophaic factories and laboratories in the United States” to offer advanced production, AI and advanced digital technologies of $ 1.2 billion dollars.
The investment commitment comes as in England for President Donald Trump for a three -day state visit.
“This week’s state visit brings together two countries that manage the world in science and health innovation. We are proud to be a part of both.” He said.
“Today, in the next 5 years, we are committed to investing at least 30 billion dollars in the United States, by increasing the strongest R -for and supply chain in the country.”
A number of global pharmaceutical companies are increasing US investments due to pressure from the Trump administration to support the US production and to miscarriage of domestic pharmaceutical prices.
Astrazeneca announced in July that it plans to invest $ 50 billion in US production and research capabilities by 2030. Novartis– Sanofi And Rocheand US -based Hand Lilly And Johnson & Johnson.
The GSK’s commitment to developed $ 1.2 billion to advanced production, the construction of a new biology factory to produce respiratory and cancer drugs in Pennsylvania, and the addition of developed digital technology capabilities in GSK’s existing digital technology capabilities in the five -existing production zones in Pennsylvania, North Carolina, Maryland and Montana.
The wider financing stems from the increasing investments of GSK’s investments in capital investments in the US supply chain and the investments made in R -GE drug discovery and development and clinical research activities.
Trump’s state visit was a profitable event with a number of companies. Microsoft– Nvidia– GoogleOpenai and Salesforce This week, the symbol of reinforced transatlantic bonds announced billions of dollars of artificial intelligence investments in the UK.
This is an developing story. Please check again for updates.
